(19)
(11) EP 0 528 951 A1

(12)

(43) Date of publication:
03.03.1993 Bulletin 1993/09

(21) Application number: 91910051.0

(22) Date of filing: 29.04.1991
(51) International Patent Classification (IPC): 
A61K 39/ 395( . )
A61P 11/ 00( . )
C07K 16/ 28( . )
C12N 15/ 09( . )
G01N 33/ 53( . )
A61K 38/ 00( . )
A61P 3/ 02( . )
A61P 31/ 12( . )
C12N 5/ 10( . )
C12P 21/ 08( . )
G01N 33/ 531( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1991/002942
(87) International publication number:
WO 1991/016927 (14.11.1991 Gazette 1991/26)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 27.04.1990 GB 19900009549

(71) Applicants:
  • CELLTECH LIMITED
    Slough Berkshire SL1 4EN (GB)
  • Boehringer Ingelheim Pharmaceuticals Inc.
    Ridgefield Connecticut 06877 (US)

(72) Inventors:
  • ADAIR, John, Robert
    High Wycombe Buckinghamshire HP14 3RN (GB)
  • ATHWAL, Diljeet, Singh
    London WC1 (GB)
  • ROTHLEIN, Robert, A.
    Danbury, CT 06811 (US)

(74) Representative: Sheard, Andrew Gregory, et al 
Kilburn & Strode 30, John Street
London WC1N 2DD
London WC1N 2DD (GB)

   


(54) HUMANIZED CDR-GRAFTED ANTI-ICAM-1 ANTIBODIES, METHODS OF PREPARATION AND USAGE THEREOF